Irshad Karim
@Lion Point Capital, Lp
Latest period2024 - Q3ReportedManaged Assets$44.907MTotal holdings25
Assets growth rate-18.13%Assets growth rate (2-Q avg)-43.74%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Lion Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 25 positions.
Assets under management
The assets under management (AUM) of Lion Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 44.907M in assets, with a quarterly growth rate of -18.13% and a 2-quarter average growth rate of -43.74%. The portfolio is managed by Irshad Karim, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
FENCFennec Pharmaceuticals Inc
| 2.4% | $1.075M 215,000 shares@ $5.0 avg price | Increased 26.48% |
BLUEBluebird Bio Inc
| 1.83% | $819,904 1.578M shares@ $0.52 avg price | Increased 132.7% |
RGNXRegenxbio Inc
| 1.35% | $605,798 57,750 shares@ $10.5 avg price | Increased 59.32% |